After AI express, investors ask questions on the investor interaction platform: May I ask the Secretary, what is the current status of our “Keguan No. 1”, whether it has entered the clinical stage, and whether it has reported relevant R & D topics?
Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) ( Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) . SZ) said on the investor interaction platform on April 2 that it is currently in the stage of scientific research and there is great uncertainty about whether it can be listed in the future.
